| __timestamp | Arrowhead Pharmaceuticals, Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 26551000 |
| Thursday, January 1, 2015 | 382000 | 50286000 |
| Friday, January 1, 2016 | 158333 | 81321000 |
| Sunday, January 1, 2017 | 31407709 | 159201000 |
| Monday, January 1, 2018 | 16142321 | 251247000 |
| Tuesday, January 1, 2019 | 168795577 | 306486000 |
| Wednesday, January 1, 2020 | 87992066 | 353874000 |
| Friday, January 1, 2021 | 138287000 | 365978000 |
| Saturday, January 1, 2022 | 243231000 | 401858000 |
| Sunday, January 1, 2023 | 240735000 | 482375000 |
| Monday, January 1, 2024 | 3551000 |
Data in motion
In the competitive landscape of biotechnology, revenue generation is a key indicator of success. Over the past decade, Corcept Therapeutics Incorporated has consistently outperformed Arrowhead Pharmaceuticals, Inc. in terms of revenue. From 2014 to 2023, Corcept's revenue surged by approximately 1,700%, peaking at nearly $482 million in 2023. In contrast, Arrowhead's revenue, while growing, reached a high of around $243 million in 2022, marking a significant increase from its modest beginnings in 2014.
Corcept's strategic focus on developing treatments for metabolic and oncologic disorders has paid off, as evidenced by its steady revenue growth. Meanwhile, Arrowhead, known for its RNA interference therapies, has shown promising revenue trends, particularly in recent years. However, the data for 2024 is incomplete, leaving room for speculation on future performance. As these companies continue to innovate, the revenue race remains a fascinating aspect of their ongoing rivalry.
Merck & Co., Inc. vs Corcept Therapeutics Incorporated: Examining Key Revenue Metrics
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Corcept Therapeutics Incorporated
Comparing Revenue Performance: BeiGene, Ltd. or Arrowhead Pharmaceuticals, Inc.?
Breaking Down Revenue Trends: Viatris Inc. vs Arrowhead Pharmaceuticals, Inc.
Annual Revenue Comparison: Ascendis Pharma A/S vs Corcept Therapeutics Incorporated
Who Generates More Revenue? Corcept Therapeutics Incorporated or Ionis Pharmaceuticals, Inc.
Breaking Down Revenue Trends: Corcept Therapeutics Incorporated vs Perrigo Company plc
Corcept Therapeutics Incorporated vs Ligand Pharmaceuticals Incorporated: Annual Revenue Growth Compared
Comparing Revenue Performance: Corcept Therapeutics Incorporated or Dynavax Technologies Corporation?
MorphoSys AG or Arrowhead Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Arrowhead Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Revenue Showdown: Arrowhead Pharmaceuticals, Inc. vs Evotec SE